Informed-money record

AKRO · Akero Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

0

Bearish filings

28

Named actors

6

Disclosed $ (bull / bear)

$0 / $8.7M

Recent disclosures

25 of 28 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2025-10-10President and CEO Cheng Andrewsold$1.6MSEC ↗
2025-10-07Chief Scientific Officer Rolph Timothysold$49KSEC ↗
2025-10-07Chief Scientific Officer Rolph Timothysold$527KSEC ↗
2025-10-01Chief Operating Officer Young Jonathansold$395KSEC ↗
2025-10-01Chief Operating Officer Young Jonathansold$202KSEC ↗
2025-09-11President and CEO Cheng Andrewsold$77KSEC ↗
2025-09-11Chief Scientific Officer Rolph Timothysold$24KSEC ↗
2025-09-11Chief Financial Officer White William Richardsold$28KSEC ↗
2025-09-11Chief Development Officer Yale Catrionasold$28KSEC ↗
2025-09-11Chief Operating Officer Young Jonathansold$25KSEC ↗
2025-09-10President and CEO Cheng Andrewsold$968KSEC ↗
2025-09-10President and CEO Cheng Andrewsold$7KSEC ↗
2025-09-10President and CEO Cheng Andrewsold$322KSEC ↗
2025-09-08Chief Scientific Officer Rolph Timothysold$551KSEC ↗
2025-09-08Chief Scientific Officer Rolph Timothysold$2KSEC ↗
2025-09-02Chief Operating Officer Young Jonathansold$3KSEC ↗
2025-09-02Chief Operating Officer Young Jonathansold$444KSEC ↗
2025-09-02Chief Operating Officer Young Jonathansold$129KSEC ↗
2025-08-12Director Henderson Janesold$142KSEC ↗
2025-08-12Chief Operating Officer Young Jonathansold$65KSEC ↗
2025-08-12Chief Operating Officer Young Jonathansold$532KSEC ↗
2025-08-11President and CEO Cheng Andrewsold$919KSEC ↗
2025-08-11President and CEO Cheng Andrewsold$519KSEC ↗
2025-08-11President and CEO Cheng Andrewsold$20KSEC ↗
2025-08-05Chief Scientific Officer Rolph Timothysold$272KSEC ↗

3 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals